All Type of News
KFDA Officially Launches Nationwide KGMP Review
The Korea Food and Drug Administration (KFDA) has initiated the nationwide review on the KGMP (Korea Good Manufacturing Practice) certified pharmaceutical facilities and their current operational practices this week, ...
Domestic Model for Corporate Pharmacy System Strongly Supported
The observations on the current corporate pharmacy practices in Japan have suggested that the retail pharmacists must fully recognize the significance as well as the implication of the corporate pharmacy system, which...
Total Number of Healthcare Providers Surpasses Over 70,000
According to the recent report released by the Health Insurance Review Agency (HIRA), there was a total of 70,394 registered healthcare providers in the nation as of year-end 2004, including hospitals, medical and den...
Astellas Pharma Korea Officially Launched
The merger between two Japanese pharmaceutical organizations, Yamanouchi Pharmaceutical Co. Ltd and Fujisawa Pharmaceutical Co. Ltd, has formed the new commercial entity under the name Astellas Pharma Korea, Inc. in t...
Scientific Discovery Shows Novel Target for Anti-Cancer Drug Development
The Korea Health Industry Development Institute (KHIDI) recently announced of a scientific discovery by Dr. Chung In-kwon and colleagues at Yonsei University on the identification of a novel cellular mechanism that co...
Large-Scale Firms Continue Gain Bigger Market Shares
The compilation report on the total revenues generated by the pharmaceutical companies last year indicates that there is an increasing level of performance gap between the large and small sized firms, indicated by a h...
KFDA Bans Antipsychotic Drugs Containing Thioridazine Hydrochloride
The Korea Food and Drug Administration (KFDA) recently announced of a decision to ban the antipsychotic drugs containing thioridazine hydrochloride in the domestic market effective July of this year.
The decision i...
KFDA Approves Atacand for Treatment of Heart Failure
AstraZeneca Korea announced that Atacand (candesarten cilexetil), an angiotensin receptor blocker (ARB) for the treatment of hypertension, has been approved by the Korea Food and Drug Administration (KFDA) for the tre...
Yuyu Sets Revenue Plan of 100 Billion Won by Year 2007
Yuyu Inc. enters the new fiscal year starting April 1st by announcing its strategic plans to become one of the leading pharmaceutical companies in the nation, achieving the revenue of 100 billion won by Year 2007.
...
SK Chemical Renamed as SK Chemicals Life Science
SK Chemical announced that the company is now operating effective April 1st under the new business entity titled SK Chemicals Life Science, upon a successful completion of its merger with SK Pharma.
Under an initia...
